The quality of our biologics and pharmaceuticals is just as important as their development. KindredBio will manufacture products under the appropriate regulatory frameworks such as Title 9 and Title 21 of the Code of Federal Regulations for products being licensed through the USDA and FDA respectively. KindredBio manufacturing sites in Burlingame, CA and Elwood, KS follow Current Good Manufacturing Practices (cGMP).
KindredBio acquired, retrofitted, and commissioned an additional manufacturing facility in Elwood, Kansas. We are uniquely positioned to meet the manufacturing needs of our promising pipeline with combined facilities reaching 180,000 square feet of full-spectrum production, from infancy to commercialization, including labeling and packaging end-to-end processes. KindredBio Clinical and Commercial Manufacturing can support the production of a broad range of biologics and pharmaceuticals. This is done through the use of single-use bioreactor (SUB) up to 2,000L in size and the use of automated vial filling, labeling, and cartoning equipment providing flexibility throughout the process.